Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jamacardio.2025.0115 | DOI Listing |
JAMA Cardiol
March 2025
Cardiology Department, University Hospital, Dijon, France.
Arch Bronconeumol
January 2025
Consorci Corporació Sanitària Parc Taulí, Pneumology Service, Sabadell, Spain; Pneumology Department, Universitat Autònoma de Barcelona, Spain.
Introduction: Patients with severe Chronic Obstructive Pulmonary Disease (COPD) often experience breathlessness and exercise limitations due to expiratory flow limitation. Pulmonary rehabilitation programmes, including exercise with non-invasive ventilation (NIV) or high-flow nasal therapy (HFT), aims to improve quality of life and exercise tolerance. This study investigates the relationship between thoracoabdominal asynchrony (TAA) during supported (NIV and HFT) and unsupported (conventional oxygen therapy - COT) exercise and clinical and functional parameters in severe COPD patients awaiting lung transplantation.
View Article and Find Full Text PDFMedicina (Kaunas)
January 2025
Department of Physiotherapy and Rehabilitation (English), Faculty of Health Sciences, Biruni University, 34015 Istanbul, Turkey.
Long COVID-19 syndrome may cause difficulties in functionality during daily life in young people. Our objective was to investigate the respiratory and functional sequelae in young adults with asymptomatic or mild COVID-19 compared with healthy peers 3-6 months and 6-12 months after COVID-19 infection. Participants aged 18-25 who had COVID-19 within the last 3-6 months (Post-COVID Group 1, n = 25) and 6-12 months (Post-COVID Group 2, n = 25) and age-gender-matched healthy controls (n = 25) were included in this study.
View Article and Find Full Text PDFEur Arch Otorhinolaryngol
March 2025
Department of Pediatric and Adolescent Medicine, Haukeland University Hospital, Bergen, Norway.
J Clin Med
December 2024
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Asahi-Machi 67, Kurume 830-0011, Japan.
The degree of exercise-induced oxygen desaturation and outcomes following antifibrotic drug therapy in asymptomatic patients with fibrosing interstitial lung disease (FILD) remain unclear. We compared clinical data, incidence of annual FILD progression, overall survival, and tolerability after initiating nintedanib between 58 patients with dyspnea and 18 patients without. Annual FILD progression was defined as >10% decrease in forced vital capacity (FVC), >15% decrease in diffusing capacity of the lungs for carbon monoxide (D), developing acute exacerbations, or FILD-related death within 1 year of starting nintedanib.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!